| pubmed-article:12781289 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12781289 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:12781289 | lifeskim:mentions | umls-concept:C0023318 | lld:lifeskim |
| pubmed-article:12781289 | lifeskim:mentions | umls-concept:C0162574 | lld:lifeskim |
| pubmed-article:12781289 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:12781289 | lifeskim:mentions | umls-concept:C0205217 | lld:lifeskim |
| pubmed-article:12781289 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:12781289 | pubmed:dateCreated | 2003-6-3 | lld:pubmed |
| pubmed-article:12781289 | pubmed:abstractText | To investigate the occurrence of advanced glycation end products (AGEs) formed oxidatively (pentosidine and N(epsilon)-carboxymethyl lysine [CML]) or nonoxidatively (imidazolone) in human lenses and the relation of AGEs to lens coloration, cataract type, and patients' diabetic state. | lld:pubmed |
| pubmed-article:12781289 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12781289 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12781289 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12781289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12781289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12781289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12781289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12781289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12781289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12781289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12781289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12781289 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12781289 | pubmed:month | May | lld:pubmed |
| pubmed-article:12781289 | pubmed:issn | 0886-3350 | lld:pubmed |
| pubmed-article:12781289 | pubmed:author | pubmed-author:SteinGünterG | lld:pubmed |
| pubmed-article:12781289 | pubmed:author | pubmed-author:NiwaToshimits... | lld:pubmed |
| pubmed-article:12781289 | pubmed:author | pubmed-author:DawczynskiJen... | lld:pubmed |
| pubmed-article:12781289 | pubmed:author | pubmed-author:StrobelJürgen... | lld:pubmed |
| pubmed-article:12781289 | pubmed:author | pubmed-author:FrankeSybille... | lld:pubmed |
| pubmed-article:12781289 | pubmed:author | pubmed-author:StahlPeterP | lld:pubmed |
| pubmed-article:12781289 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12781289 | pubmed:volume | 29 | lld:pubmed |
| pubmed-article:12781289 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12781289 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12781289 | pubmed:pagination | 998-1004 | lld:pubmed |
| pubmed-article:12781289 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12781289 | pubmed:meshHeading | pubmed-meshheading:12781289... | lld:pubmed |
| pubmed-article:12781289 | pubmed:meshHeading | pubmed-meshheading:12781289... | lld:pubmed |
| pubmed-article:12781289 | pubmed:meshHeading | pubmed-meshheading:12781289... | lld:pubmed |
| pubmed-article:12781289 | pubmed:meshHeading | pubmed-meshheading:12781289... | lld:pubmed |
| pubmed-article:12781289 | pubmed:meshHeading | pubmed-meshheading:12781289... | lld:pubmed |
| pubmed-article:12781289 | pubmed:meshHeading | pubmed-meshheading:12781289... | lld:pubmed |
| pubmed-article:12781289 | pubmed:meshHeading | pubmed-meshheading:12781289... | lld:pubmed |
| pubmed-article:12781289 | pubmed:meshHeading | pubmed-meshheading:12781289... | lld:pubmed |
| pubmed-article:12781289 | pubmed:meshHeading | pubmed-meshheading:12781289... | lld:pubmed |
| pubmed-article:12781289 | pubmed:meshHeading | pubmed-meshheading:12781289... | lld:pubmed |
| pubmed-article:12781289 | pubmed:meshHeading | pubmed-meshheading:12781289... | lld:pubmed |
| pubmed-article:12781289 | pubmed:meshHeading | pubmed-meshheading:12781289... | lld:pubmed |
| pubmed-article:12781289 | pubmed:meshHeading | pubmed-meshheading:12781289... | lld:pubmed |
| pubmed-article:12781289 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12781289 | pubmed:articleTitle | Increased levels of advanced glycation end products in human cataractous lenses. | lld:pubmed |
| pubmed-article:12781289 | pubmed:affiliation | Department of Internal Medicine III, Friedrich Schiller University of Jena, 07740 Jena, Germany. sybille.franke@med.uni-jena.de | lld:pubmed |
| pubmed-article:12781289 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12781289 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12781289 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12781289 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12781289 | lld:pubmed |
